CancerVAX is a pre-clinical biotechnology company based in Marina del Rey, CA, working in collaboration with UCLA to develop innovative immunotherapy cancer treatments that harness the body's immune system to combat cancer. Their goal is to create transformative therapies that protect and enhance the lives of individuals affected by cancer.
With a focus on simplicity and effectiveness, CancerVAX is developing immunotherapy technologies that can be administered through simple injections, envisioning a future where cancer treatment is as straightforward as receiving a flu shot. Their pipeline includes disease-specific immunotherapy for pediatric cancer, a customizable Universal Cancer Vaccine, and a low-cost treatment platform that reprograms the body's own immune T-cells to target and destroy cancer cells with precision.
Generated from the website